Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05483855 · ClinicalTrials.gov registry record
Telehealth-delivered HealthcaRe to ImproVe Care
A clinical trial of Telemedicine, sponsored by Attune Health Research.
- Recruiting
- Registry status
- 1,580
- Enrollment target
- 1
- Study location
NCT05483855: Recruiting study of Telemedicine, sponsored by Attune Health Research.
NCT05483855 is a study of Telemedicine that is actively recruiting participants, run by Attune Health Research. The registered enrollment target is 1,580 participants, below the 3,969-participant average among 18 other Telemedicine trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05483855, a study of Telemedicine, is actively recruiting participants, sponsored by Attune Health Research.
- RECRUITING
- Registry status
- 1,580 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment examinations to observe and report the number of tender and swollen joint counts.
Conditions Studied
Interventions
- OTHER Objective 1 Only: Telehealth Satisfaction Survey
- OTHER Objective 2 Only: ArthritisPower Joint Assessment
Study Locations (1)
California
- Attune Health Research Inc - Beverly Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,580 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2025-04 |
What NCT05483855 shows while recruiting
NCT05483855 is an observational study that tracks outcomes without assigning an intervention. Its 1,580 participants enrollment target places it among the larger protocols in the corpus, below the 3,969-participant average among 18 other Telemedicine trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Telemedicine appearing as the primary indexed condition, and to 2 interventions - of which Objective 1 Only: Telehealth Satisfaction Survey is the first listed.
NCT05483855 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05483855 about?
NCT05483855 is a clinical study titled "Telehealth-delivered HealthcaRe to ImproVe Care". Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment...
What is the current status of trial NCT05483855?
This trial is currently recruiting. The enrollment target is 1,580 participants. The study started on 2023-01-03. Estimated completion is 2025-04.
What conditions does trial NCT05483855 study?
This clinical trial studies the following conditions: Telemedicine.
What interventions are being tested in trial NCT05483855?
The interventions under investigation include: Objective 1 Only: Telehealth Satisfaction Survey (OTHER), Objective 2 Only: ArthritisPower Joint Assessment (OTHER).
Who is sponsoring clinical trial NCT05483855?
This trial is sponsored by Attune Health Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05483855 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Telemedicine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05483855's enrollment target sits among peer trials
1,580 7th of 18 higher than 12 of 18 other Telemedicine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Telemedicine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Integrating Telehealth to Advance Lung Cancer Screening
RECRUITING · NA
-
Integrated Telemedicine Program Evaluation
RECRUITING · NA
-
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
RECRUITING · NA
-
The Actuate-CBC Study
RECRUITING
-
TeleMAb Retrospective Cohort Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NCT06632457 · 1,590 participants · Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- NCT05243797 · 1,594 participants · Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI